Evidence map›Paper›PMID 24047466›Full record

ArticleAmerican journal of respiratory cell and molecular biology2013

Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

Gregory B Waypa, Scott W Osborne, Jeremy D Marks, Sara K Berkelhamer, Jyothisri Kondapalli, Paul T Schumacker

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.American journal of respiratory cell and molecular biology · 2023
    Article
  4. Boosting the Exhausted Vasculature-SIRT3 (to the) Rescue.American journal of respiratory cell and molecular biology · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. SIRT3: A New Regulator of Cardiovascular Diseases.Oxidative medicine and cellular longevity · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gregory B WaypaDepartment of Pediatrics, Division of Neonatology 1 , Northwestern University Feinberg School of Medicine, Chicago, Illinois; and.
Scott W Osborne
Jeremy D Marks
Sara K Berkelhamer
Jyothisri Kondapalli
Paul T Schumacker
Northwestern University · USUniversity of Chicago · US

Funding

Respiratory and Metabolic Adaptation to HypoxiaR01HL035440 · NHLBI · UNIVERSITY OF CHICAGO · PI SCHUMACKER, PAUL T · 1986 to 2018
$5.0M
Mechanisms of Co-Polymer-Mediated NeuroprotectionR01NS056313 · NINDS · UNIVERSITY OF CHICAGO · PI MARKS, JEREMY D · 2007 to 2011
$1.8M
O2 Sensing in Hypoxic Pulmonary VasoconstrictionR01HL079650 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHUMACKER, PAUL T · 2005 to 2009
$1.6M
O2 SENSING BY MITOCHONDRIA DURING INTERMITTENT HYPOXIAR01HL066315 · NHLBI · UNIVERSITY OF CHICAGO · PI SCHUMACKER, PAUL T. · 2000 to 2003
$1.1M
NHLBI NIH HHS HL079650NHLBI NIH HHS HL35440NHLBI NIH HHS HL66315NHLBI NIH HHS R01 HL035440NHLBI NIH HHS R01 HL066315NHLBI NIH HHS R01 HL079650NINDS NIH HHS NS056313NINDS NIH HHS R01 NS056313
6 · The paper itself

Abstract

Alveolar hypoxia elicits increases in mitochondrial reactive oxygen species (ROS) signaling in pulmonary arterial (PA) smooth muscle cells (PASMCs), triggering hypoxic pulmonary vasoconstriction. Mice deficient in sirtuin (Sirt) 3, a nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase, demonstrate enhanced left ventricular hypertrophy after aortic banding, whereas cells from these mice reportedly exhibit augmented hypoxia-induced ROS signaling and hypoxia-inducible factor (HIF)-1 activation. We therefore tested whether deletion of Sirt3 would augment hypoxia-induced ROS signaling in PASMCs, thereby exacerbating the development of pulmonary hypertension (PH) and right ventricular hypertrophy. In PASMCs from Sirt3 knockout (Sirt3(-/-)) mice in the C57BL/6 background, we observed that acute hypoxia (1.5% O2; 30 min)-induced changes in ROS signaling, detected using targeted redox-sensitive, ratiometric fluorescent protein sensors (roGFP) in the mitochondrial matrix, intermembrane space, and the cytosol, were indistinguishable from Sirt3(+/+) cells. Acute hypoxia-induced cytosolic calcium signaling in Sirt3(-/-) PASMCs was also indistinguishable from Sirt3(+/+) cells. During sustained hypoxia (1.5% O2; 16 h), Sirt3 deletion augmented mitochondrial matrix oxidant stress, but this did not correspond to an augmentation of intermembrane space or cytosolic oxidant signaling. Sirt3 deletion did not affect HIF-1α stabilization under normoxia, nor did it augment HIF-1α stabilization during sustained hypoxia (1.5% O2; 4 h). Sirt3(-/-) mice housed in chronic hypoxia (10% O2; 30 d) developed PH, PA wall remodeling, and right ventricular hypertrophy that was indistinguishable from Sirt3(+/+) littermates. Thus, Sirt3 deletion does not augment hypoxia-induced ROS signaling or its consequences in the cytosol of PASMCs, or the development of PH. These findings suggest that Sirt3 responses may be cell type specific, or restricted to certain genetic backgrounds.

Indexed as

AnimalsCalcium SignalingFemaleHypertension, PulmonaryHypertrophy, Right VentricularHypoxiaHypoxia-Inducible Factor 1, alpha SubunitMaleMiceMice, Inbred C57BLMice, KnockoutMitochondria, MuscleMyocytes, Smooth MusclePulmonary ArteryReactive Oxygen SpeciesSirtuin 3Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitReactive Oxygen SpeciesSirt3 protein, mouseSirtuin 3

Identifiers

PMID24047466
PMCPMC3931121
OpenAlexW2088698457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.